ストックスクリーナーアプリを入手
5.97
1.36%
0.08
前日終値:
$5.89
開ける：
$5.82
24時間の取引高:
2,052
Relative Volume:
0.27
時価総額：
$82.90M
収益：
$57.94M
当期純損益:
$-2.34M
株価収益率:
-35.83
EPS:
-0.1666
ネットキャッシュフロー:
$3.82M
1週間 パフォーマンス:
+1.02%
1か月 パフォーマンス:
+3.47%
6か月 パフォーマンス:
-12.21%
1年 パフォーマンス:
-0.83%
1日の値動き範囲:
$5.82
$5.97
1週間の範囲:
$5.72
$6.00
52週間の値動き範囲:
$5.50
$9.6299
Champions Oncology Inc Stock (CSBR) Company Profile
名前
Champions Oncology Inc
セクター
電話
410-369-0365
住所
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
5.97 | 81.79M | 57.94M | -2.34M | 3.82M | -0.1666 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-12 | アップグレード | Craig Hallum | Hold → Buy |
| 2019-11-18 | 開始されました | The Benchmark Company | Speculative Buy |
Champions Oncology Inc (CSBR) 最新ニュース
Leading Companies Enhancing Their Presence in the Tumor Models Market - openPR.com
Patient-Derived Xenograft (PDX) Models Market (2026-2033) | - openPR.com
Champions Oncology (NASDAQ:CSBR) Shares Cross Below 200-Day Moving AverageWhat's Next? - MarketBeat
Liquidity Mapping Around (CSBR) Price Events - Stock Traders Daily
Champions Onc (CSBR) Stock: Is It Forming a Pattern (Market Focus) 2026-04-27Social Flow Trades - Newser
Champions Oncology (CSBR) Proxy Filing Summary - Quartr
Champions Oncology (NASDAQ:CSBR) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Radiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand - Dailyhunt
Data4Cure Presents a Foundation Model for Forward and Reverse Translation at AACR 2026 Annual Meeting - Scott Coop
Elisrasib Demonstrates High DCR in KRAS G12C+ NSCLC - The ASCO Post
Champions Onc (CSBR) Stock: Growth vs Risks (-0.98%) 2026-04-18Reversal Signals - Xã Vĩnh Công
Cavco Industries Jumps 7.1% Amid Sector-Wide Selling - AlphaStreet
Why (CSBR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Champions Oncology (NASDAQ:CSBR) Stock Crosses Above Fifty Day Moving AverageShould You Sell? - MarketBeat
Aug Decliners: How does Champions Oncology Inc compare to its peersMarket Activity Report & Growth Focused Investment Plans - baoquankhu1.vn
Aug Catalysts: What is Champions Oncology Incs debt to equity ratio2026 Macro Moves & Consistent Return Investment Signals - baoquankhu1.vn
Chipmakers Recap: Should I average down on ACMR stockWeekly Profit Recap & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Comedian Michael Kosta Headlines Karmanos Comedy Champions - PR Newswire
CSBR Should I Buy - Intellectia AI
Champions Oncology to present eight studies at AACR meeting By Investing.com - Investing.com Australia
Champions Oncology to present eight studies at AACR meeting - Investing.com
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026 - ACCESS Newswire
Eight cancer studies from Champions Oncology focus on drug response, resistance - Stock Titan
Bond Watch: Can Champions Oncology Inc weather a recessionWeekly Trading Summary & Verified Technical Signals - baoquankhu1.vn
Patient Derived Xenograft (PDX) Models Market is estimated - openPR.com
How does Champions Oncology Inc compare to its peers2026 Biggest Moves & Growth-Oriented Investment Plans - baoquankhu1.vn
Fennec Pharmaceuticals Inc. (FENC) stock price, news, quote and history - Yahoo Finance UK
CSBR Forecast, Price Target & Analyst Ratings | CHAMPIONS ONCOLOGY INC (NASDAQ:CSBR) - ChartMill
Understanding Momentum Shifts in (CSBR) - Stock Traders Daily
Performance Recap: What is Champions Oncology Incs debt to equity ratioMarket Risk Summary & Community Trade Idea Sharing - baoquankhu1.vn
CSBR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Champions Oncology, Inc.Common Stock (NQ: CSBR - The Chronicle-Journal
Market Review: How correlated is Champions Oncology Inc to the S P5002026 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn
Global Tumor Models Market Set to Soar from $2.37B in 2026 - GlobeNewswire
Datavault AI Inc. (NASDAQ: DVLT) and Demora Foundation Execute Technology Integration Agreement to Power the K-Entertainment & K-Wave Global Platform - STT Info
CSBR PE Ratio & Valuation, Is CSBR Overvalued - Intellectia AI
Datavault AI Returns a Second Time for Exclusive Investor Forum at Mar-a-Lago - NTB Kommunikasjon
Jenny Hammarberg Appointed CEO of LawlineBringing Legal Expertise to Users Through AI - STT Info
Datavault AI and Coppercore Inc. Announce Tokenization of High-Grade Copper Resources into Coppercoin(TM) - STT Info
Champions Oncology appoints Brian Alexander to board By Investing.com - Investing.com Australia
The World's First Agentic CMS Just Got Smarter: Kontent.ai Launches Expert Agents - Via Ritzau
Risk Off: How does Champions Oncology Inc compare to its peersLayoff News & Technical Pattern Based Buy Signals - baoquankhu1.vn
Champions Oncology Adds Director to Advance Data-Driven Strategy - TipRanks
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - irw-press.com
Champ appoints Dr. Brian Alexander to board after Dr. Philip Breitfeld resignation - TradingView
Brian Alexander joins Champions Oncology (NASDAQ: CSBR) board - Stock Titan
Stock Market Recap: Will Champions Oncology Inc benefit from geopolitical trends2026 Bull vs Bear & Safe Entry Momentum Tips - baoquankhu1.vn
Champions Oncology appoints Brian Alexander to board - Investing.com
Champions Oncology taps data-focused cancer doctor for board seat - Stock Titan
Mandela Dollar ("MUSD") Announced to Promote Mandela's Legacy of Financial Inclusion for Underserved Communities Across the World - STT Info
Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce - STT Info
Champions Oncology Inc (CSBR) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):